What if you'd held ASND?
A $1,000 investment in Ascendis Pharma A/S (ASND) at the month-end close of 2015-01 would be worth $13,092 at the close of 2026-08 — +1209.2% total return, dividends reinvested. The same $1,000 in the S&P 500 would be worth $3,864.
Your scenario
Result
If you'd bought $1,000 at the start of each year
Value of $1,000 invested on January 1 of each year, held to 2026-08, dividends included.
Every year, $1,000 from 2015
| Year | Value of $1,000 | Year return |
|---|---|---|
| 2015 | $1,000 | — |
| 2016 | $1,105 | +10.5% |
| 2017 | $2,187 | +97.9% |
| 2018 | $3,420 | +56.4% |
| 2019 | $7,594 | +122.1% |
| 2020 | $9,104 | +19.9% |
| 2021 | $7,343 | -19.3% |
| 2022 | $6,666 | -9.2% |
| 2023 | $6,875 | +3.1% |
| 2024 | $7,515 | +9.3% |
| 2025 | $11,640 | +54.9% |
| 2026 | $14,171 | +21.8% |
Best and worst month-end to buy
The best single month-end close to have bought ASND was 2016-06 ($13.27): $1,000 then is $19,564 today. The worst was 2026-06 ($267): $1,000 then is $973.
FAQ
What would $1,000 in ASND be worth today?
A $1,000 investment in Ascendis Pharma A/S (ASND) at the start of 2015 would be worth about $13,092 today, a total return of +1209.2%. Dividends are reinvested in these figures.
What were the best and worst years for ASND?
Ascendis Pharma A/S (ASND)'s strongest calendar year since 2015 was 2019, a +122.1% return — $1,000 held through that year became about $2,221 by year-end. Its weakest year was 2021, at -19.3%.
Does the calculator include dividends and splits?
Yes where available. Prices are adjusted for both stock splits and reinvested dividends (total return), the same measure brokerages use.
How much would $100 per month in ASND have grown?
Investing $100 at the end of every month since 2015-01 would have grown to about $69,220 on $14,000 invested.
Did ASND beat the S&P 500?
Over the same period, $1,000 in the S&P 500 index would be worth $3,864. ASND beat the S&P 500 by +238.9% in total return.
Is this investment advice?
No. Wall Street Regrets is an entertainment and education tool. Every number is a historical calculation, not a prediction, and past performance never guarantees future results.
Methodology
Ascendis Pharma A/S (ASND) historical total-return data from 2015-01 to 2026-08, reduced to month-end closes for the tables above.
Returns use adjusted close prices from Yahoo Finance historical data — adjusted for stock splits and reinvested dividends — the same convention used by major brokerages. A "year" scenario invests $1,000 at the prior December's month-end close and values it at the latest available month-end close. Non-USD amounts are converted at historical month-end exchange rates (Yahoo Finance): to USD on the buy date and back to your currency at the latest rate, so the return reflects the currency move as well as the asset.
Month-end resolution means intra-month extremes are not captured in tables; the calculator uses exact trading-day closes where daily data is available. Figures ignore taxes, fees, and the currency effects of non-USD listings. History is not a forecast. Wall Street Regrets is entertainment, not investment advice.
What if you'd held…
Data: adjusted close prices via Yahoo Finance. As of 2026-08. Not financial advice.